Comparison of structures and cytotoxicity of mupirocin and batumin against melanoma and several other cancer cell lines

Show simple item record

dc.contributor.author Reva, Oleg N.
dc.contributor.author Rademan, Sunelle
dc.contributor.author Visagie, M.H. (Michelle Helen)
dc.contributor.author Lebelo, M.T. (Maphuti)
dc.contributor.author Gwangwa, Mokgadi Violet
dc.contributor.author Klochko, Vitalii V.
dc.contributor.author Joubert, Anna Margaretha
dc.contributor.author Lall, Namrita
dc.date.accessioned 2019-06-19T13:54:51Z
dc.date.available 2019-06-19T13:54:51Z
dc.date.issued 2019
dc.description.abstract AIM : To determine the computer-predicted anticancer activity of mupirocin and to compare its activities with those determined for another polyene antibiotic, batumin. MATERIALS AND METHODS : Molecular docking, cytotoxicity assays, cell microscopy and cell cycle progression were studied in cancer and nontumorigenic cell lines. RESULTS AND CONCLUSION : Cytotoxicity of mupirocin against several cancerous cell lines was detected with the highest one (IC50 = 5.4 μg/ml) against melanoma cell line. The profile of cytotoxicity of mupirocin was similar to that reported for batumin. Nevertheless, the morphology of cells treated with these antibiotics and alterations in cell cycle progression suggested possible dissimilarity in their mechanisms of action. Selective cytotoxicity of mupirocin against melanoma cells potentiates further studies to discover nontoxic drugs for melanoma prevention. en_ZA
dc.description.department Biochemistry en_ZA
dc.description.department Genetics en_ZA
dc.description.department Microbiology and Plant Pathology en_ZA
dc.description.department Physiology en_ZA
dc.description.department Plant Production and Soil Science en_ZA
dc.description.librarian hj2019 en_ZA
dc.description.sponsorship AM Joubert acquired grants from the National Research Foundation (NRF; 105992, 90523 and 85818), Cancer Association of South Africa (A0V741 and A0W228), the Struwig Germeshuysen Trust (A0N074), the School of Medicine Research Committee of the University of Pretoria (AOH561) and Medical Research Council (A0W110). MH Visagie was funded from the NRF (99706), the School of Medicine Research Committee of the University of Pretoria (AOH561) and Struwig Germeshysen Trust. N Lall was funded from NRF/IKS160514165042 Grant No: 105169. ON Reva was funded from NRF grant 105996. en_ZA
dc.description.uri https://www.future-science.com/journal/fmc en_ZA
dc.identifier.citation Reva, O.N., Rademan, S., Visagie, M.H. et al. 2019, 'Comparison of structures and cytotoxicity of mupirocin and batumin against melanoma and several other cancer cell lines', Future Medicinal Chemistry, vol. 11, no. 7, pp. 677-691. en_ZA
dc.identifier.issn 1756-8919 (print)
dc.identifier.issn 1756-8927 (online)
dc.identifier.other 10.4155/fmc-2018-0333
dc.identifier.uri http://hdl.handle.net/2263/70250
dc.language.iso en en_ZA
dc.publisher Future Science en_ZA
dc.rights © 2019 Future Science Group en_ZA
dc.subject Computer-predicted anticancer activity en_ZA
dc.subject Mupirocin en_ZA
dc.subject Polyene antibiotic en_ZA
dc.subject Batumin en_ZA
dc.subject Cancer cell lines en_ZA
dc.subject Nontumorigenic cell lines en_ZA
dc.subject Molecular docking en_ZA
dc.subject Cell cycle progression en_ZA
dc.subject Cytotoxicity assays en_ZA
dc.subject Cell microscopy en_ZA
dc.subject Melanoma en_ZA
dc.subject Drug design en_ZA
dc.subject Prophylaxis en_ZA
dc.title Comparison of structures and cytotoxicity of mupirocin and batumin against melanoma and several other cancer cell lines en_ZA
dc.type Preprint Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record